Evidence map›Paper›PMID 31752700›Full record

ArticleBMC geriatrics2019

An inventory of collaborative medication reviews for older adults - evolution of practices.

A Kiiski, M Airaksinen, A Mäntylä, S Desselle, A Kumpusalo-Vauhkonen, T Järvensivu, M Pohjanoksa-Mäntylä

Abstract read
In one paragraph

Article in BMC geriatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A KiiskiClinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki , PO Box 56, 00014, Helsinki, Finland. Annika.kiiski@helsinki.fi.ORCID 0000-0003-3107-3854
M AiraksinenClinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki , PO Box 56, 00014, Helsinki, Finland.ORCID 0000-0002-6077-5671
A MäntyläFinnish Medicines Agency Fimea, PO Box 55, 00034, Helsinki, Finland.
S DesselleCollege of Pharmacy, Touro University California, 1310 Club Drive Mare Island Vallejo, California, CA, 94592, USA.ORCID 0000-0002-5987-1391
A Kumpusalo-VauhkonenFinnish Medicines Agency Fimea, PO Box 55, 00034, Helsinki, Finland.
T JärvensivuAalto University, PO Box 11000, FI-00076 AALTO, Espoo, Finland.
M Pohjanoksa-MäntyläClinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki , PO Box 56, 00014, Helsinki, Finland.ORCID 0000-0002-7933-4200

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCollaborative medication review (CMR) practices for older adults are evolving in many countries. Development has been under way in Finland for over a decade, but no inventory of evolved practices has been conducted. The aim of this study was to identify and describe CMR practices in Finland after 10 years of developement.

methodsAn inventory of CMR practices was conducted using a snowballing approach and an open call in the Finnish Medicines Agency's website in 2015. Data were quantitatively analysed using descriptive statistics and qualitatively by inductive thematic content analysis. Clyne et al's medication review typology was applied for evaluating comprehensiveness of the practices.

resultsIn total, 43 practices were identified, of which 22 (51%) were designed for older adults in primary care. The majority (n = 30, 70%) of the practices were clinical CMRs, with 18 (42%) of them being in routine use. A checklist with criteria was used in 19 (44%) of the practices to identify patients with polypharmacy (n = 6), falls (n = 5), and renal dysfunction (n = 5) as the most common criteria for CMR. Patients were involved in 32 (74%) of the practices, mostly as a source of information via interview (n = 27, 63%). A medication care plan was discussed with the patient in 17 practices (40%), and it was established systematically as usual care to all or selected patient groups in 11 (26%) of the practices. All or selected patients' medication lists were reconciled in 15 practices (35%). Nearly half of the practices (n = 19, 44%) lacked explicit methods for following up effects of medication changes. When reported, the effects were followed up as a routine control (n = 9, 21%) or in a follow-up appointment (n = 6, 14%).

conclusionsDifferent MRs in varying settings were available and in routine use, the majority being comprehensive CMRs designed for primary outpatient care and for older adults. Even though practices might benefit from national standardization, flexibility in their customization according to context, medical and patient needs, and available resources is important.

Indexed as

PolypharmacyAgedAmbulatory CareDrug Utilization ReviewFemaleFinlandHumansMalePractice Patterns, Physicians'Adherence reviewCollaborative medication reviewComprehensive medication reviewConcordance and compliance reviewMedicines optimizationOlder adultsPrescription review

Identifiers

PMID31752700
PMCPMC6873748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.